603658 安圖生物
按盤價 
56.350 +0.120 (+0.213%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,089,195 | 5.09% | 4,443,656 | 4,441,627 | 3,765,917 | 2,978,132 | |
| 減：營業總成本 | 777,943 | -0.98% | 3,214,960 | 3,278,389 | 2,832,095 | 2,193,102 | |
| 其中:營業成本 | 386,453 | -4.26% | 1,552,245 | 1,783,657 | 1,525,628 | 1,198,723 | |
| 財務費用 | 2,054 | 144.64% | 8,788 | (2,041) | 14,589 | 20,863 | |
| 資產減值損失 | 1,374 | -105.04% | (32,692) | (35,777) | (619) | (1,664) | |
| 公允價值變動收益 | 3,407 | -- | 580 | -- | 33 | 94 | |
| 投資收益 | 22,968 | -38.03% | 129,381 | 118,585 | 108,346 | 49,888 | |
| 其中：對聯營企業和合營企業的投資收益 | (1,257) | 1,425.91% | (3,369) | 2,000 | 76 | 4,704 | |
| 營業利潤 | 363,984 | 34.36% | 1,365,748 | 1,296,382 | 1,076,152 | 856,366 | |
| 利潤總額 | 361,812 | 32.90% | 1,362,544 | 1,293,715 | 1,065,549 | 844,533 | |
| 減：所得稅費用 | 33,113 | 32.07% | 138,413 | 105,033 | 85,693 | 87,442 | |
| 淨利潤 | 328,699 | 32.98% | 1,224,131 | 1,188,682 | 979,856 | 757,091 | |
| 減：非控股權益 | 4,487 | -12.06% | 6,692 | 21,245 | 6,193 | 9,297 | |
| 股東淨利潤 | 324,212 | 33.93% | 1,217,439 | 1,167,437 | 973,663 | 747,794 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.560 | 33.33% | 2.100 | 2.000 | 1.660 | 1.340 | |
| 每股派息 (元) * | -- | -- | 1.050 | 0.800 | 0.720 | 0.850 | |
| 每股淨資產 (元) * | 14.976 | 9.41% | 14.559 | 13.275 | 12.412 | 14.363 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 26/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
